Perrigo Company PLC  

(Public, TLV:PRGO)   Watch this stock  
Find more results for Todd Cohen
52,980.00
+40.00 (0.08%)
Jul 29 - Close
TLV data delayed by 20 mins - Disclaimer
Currency in ILA unless noted
Range 52,520.00 - 53,050.00
52 week 446.00 - 53,050.00
Open 52,830.00
Vol / Avg. 26,862.00/74,051.00
Mkt cap     -
P/E     -
Div/yield     -
EPS     -
Shares 133.80M
Beta     -
Inst. own     -
*ILS

Description

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

Officers and directors

Joseph C. Papa Chairman of the Board, President, Chief Executive Officer
Age: 58
Judy L. Brown Chief Financial Officer, Executive Vice President
Age: 45
Todd W. Kingma Executive Vice President, General Counsel, Secretary
Age: 53
Douglas S. Boothe Executive Vice President, General Manager - Rx Pharmaceuticals
Age: 49
Scott F. Jamison Executive Vice President, General Manager - Nutritionals
Age: 57
Sharon Kochan Executive Vice President, General Manager - International
Age: 45
Jeffrey R. Needham Executive Vice President, General Manager - Consumer Healthcare
Age: 57
John T. Hendrickson Executive Vice President - Global Operations and Supply Chain
Age: 50
Louis W. Yu Ph.D. Executive Vice President - Global Quality
Age: 62
Thomas M. Farrington Senior Vice President, Chief Information Officer
Age: 56